AAV Vectors - Clinical Studies I

Who can view: Everyone

Webinar Price: Free

Featured Presenters

David Weinstein, MD, MMSc

Professor and Director, Glycogen Storage Disease program

Weinstein@uchc.edu

VIEW PROFILE

Alvin Luk

CEO at Neurophth Therapeutics, Inc.

Our mission is to discover and develop new gene therapies that will change the way to see the world.

VIEW PROFILE

ASGCT 23rd Annual Meeting

The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.

VIEW CHANNEL CONTACT

Attended (1518)

Recommended

.js-disable-section{ top: 0px; left: 5%; position: fixed; width: 90%; height: auto; margin: 0px; padding: 0px; z-index: 9999999; } .js-bme-box{ box-shadow: rgba(0, 0, 0, 0.1) 0px 2px 4px; background-color: rgb(255, 0, 0); border-color: darkred; color: rgb(255, 255, 255); background-image: linear-gradient(to right, rgb(255, 49, 110), rgb(245, 53, 113)); border-radius: 0px 0px 5px 5px; text-align: center; } .js-bme-box span{ font-size: 18px; text-align: center; padding: 13px 10px; position: relative; font-family: 'ModernSans', Arial, Helvetica, sans-serif; font-weight: normal; line-height: 50px; } #register_with_pre_response, #register_with_pre_response_template, #submit_registration_button{ pointer-events:none !important; opacity: 0.5 !important; }

Javascript is required to complete registration. Please enable Javascript in your browser, or contact support for instruction on how to do so.

AAV Vectors - Clinical Studies I

AAV Vectors - Clinical Studies I

Steven Gray

Olivier Danos

David Weinstein, MD, MMSc

Alvin Luk

Dmitry Kuzmin

Eileen Sawyer

Michael Castle

Anne Marie Conway

ASGCT 23rd Annual Meeting